Bradley Merrill Thompson Quoted in “Amazon, FDA Meeting a Harbinger for Potential Healthcare Move”

Bradley Merrill Thompson, a Member of the Health Care and Life Sciences practice in the Washington, DC office, was quoted in "Amazon, FDA Meeting a Harbinger for Potential Healthcare Move."

Following is an excerpt:

Is Amazon poised to join the fray of large technology companies jumping into the healthcare space?

Amazon representatives met with Howard Sklamberg, the U.S. Food and Drug Administration's deputy commissioner for global regulatory operations and policy, late last month, according to a report by VentureBeat. That, in addition to the July hiring of Babak Parviz, an ex-Google employee who renowned for developingGoogle Glass and the company's smart contact lens, point to a potential move for Amazon, the article predicts.

Brad Thompson, a health attorney with Epstein Becker Green, tells VentureBeatthat Sklamberg is "one of the most high-ranking officials at the FDA on the policy side," adding that from his purview, Amazon might be looking to "stitch together existing wearables into some sort of system."

Thompson also speculates that Amazon could be considering a health platform of its own that involves the company's new phone.